Lanzheng Bian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lanzheng Bian has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ailing Xie
Children's Hospital of Nanjing Medical University Nanjing China
1 shared publication- Jianping Yang
Children's Hospital of Nanjing Medical University, No.72 Guangzhou road, Gulou district, Nanjing, Jiangsu province, China
1 shared publication Junyu Chen
Children's Hospital of Nanjing Medical University Nanjing China
1 shared publicationLi Wei
Children's Hospital of Nanjing Medical University Nanjing China
1 shared publication- Li Wei
Children's Hospital of Nanjing Medical University, No.72 Guangzhou road, Gulou district, Nanjing, Jiangsu province, China
1 shared publication - Li Wei
Department of oncology, People’s Hospital of Guizhou province, Guiyang City, China
1 shared publication
Latest Publications
- Open Access
- 16 May 2019
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-12
Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis
Several randomized controlled trials (RCTs) evaluated the role of Chlorhexidine-impregnated dressing for prophylaxis of central venous catheter (CVC) related complications, but the results remained inconsistent, updated meta-analyses on this issue are warranted. A meta-analysis on the RCTs comparing Chlorhexidine-impregnated dressing versus other dressing or no dressing for prophylaxis of central venous catheter-related complications was performed. A comprehensive search of major databases was undertaken up to 30 Dec 2018 to identify related studies. Pooled odd ratio (OR) and mean differences (MDs) with 95% confidence intervals (CI) were calculated using either a fixed-effects or random-effects model. Subgroup analysis was performed to identify the source of heterogeneity, and funnel plot and Egger test was used to identify the publication bias. A total of 12 RCTs with 6028 patients were included. The Chlorhexidine-impregnated dressings provided significant benefits in reducing the risk of catheter colonization (OR = 0.46, 95% CI: 0.36 to 0.58), decreasing the incidence of catheter-related bloodstream infection (CRBSI) (OR = 0.60, 95% CI: 0.42 to 0.85). Subgroup analysis indicated that the Chlorhexidine-impregnated dressings were conducive to reduce the risk of catheter colonization and CRBSI within the included RCTs with sample size more than 200, but the differences weren’t observed for those with sample less than 200. No publication bias was observed in the Egger test for the risk of CRBSI. Chlorhexidine-impregnated dressing is beneficial to prevent CVC-related complications. Future studies are warranted to assess the role and cost-effectiveness of Chlorhexidine-impregnated dressings.
- 16 May 2019
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-12
Open AccessChlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis
Several randomized controlled trials (RCTs) evaluated the role of Chlorhexidine-impregnated dressing for prophylaxis of central venous catheter (CVC) related complications, but the results remained inconsistent, updated meta-analyses on this issue are warranted. A meta-analysis on the RCTs comparing Chlorhexidine-impregnated dressing versus other dressing or no dressing for prophylaxis of central venous catheter-related complications was performed. A comprehensive search of major databases was undertaken up to 30 Dec 2018 to identify related studies. Pooled odd ratio (OR) and mean differences (MDs) with 95% confidence intervals (CI) were calculated using either a fixed-effects or random-effects model. Subgroup analysis was performed to identify the source of heterogeneity, and funnel plot and Egger test was used to identify the publication bias. A total of 12 RCTs with 6028 patients were included. The Chlorhexidine-impregnated dressings provided significant benefits in reducing the risk of catheter colonization (OR = 0.46, 95% CI: 0.36 to 0.58), decreasing the incidence of catheter-related bloodstream infection (CRBSI) (OR = 0.60, 95% CI: 0.42 to 0.85). Subgroup analysis indicated that the Chlorhexidine-impregnated dressings were conducive to reduce the risk of catheter colonization and CRBSI within the included RCTs with sample size more than 200, but the differences weren’t observed for those with sample less than 200. No publication bias was observed in the Egger test for the risk of CRBSI. Chlorhexidine-impregnated dressing is beneficial to prevent CVC-related complications. Future studies are warranted to assess the role and cost-effectiveness of Chlorhexidine-impregnated dressings.
- 9 December 2018
- Published by Wiley in Nursing in Critical Care
- Vol. 24 (2) , 76-82
Is continuous better than intermittent control of tracheal cuff pressure? A meta‐analysis
Aim: To compare and evaluate the efficacy and safety of continuous and intermittent control of cuff pressure.Methods: We performed a comprehensive and systematic meta‐analysis of randomized controlled trials (RCTs) assessing the continuous and intermittent control of Pcuff by searching PUBMED, EMBASE and other such databases (from inception to 31 March 2018). Summary odds ratios or mean differences with 95% confidence intervals were calculated using a fixed‐ or random‐effects model.Measurements and Main Results: Seven randomised controlled trials with 970 mechanically ventilated patients were included in this study. The continuous control of cuff pressure significantly reduced the incidence of cuff pressure < 20 cm H2O (0.03 (OR) (95% CI: 0.01–0.07)), Pcuff > 30 cm H2O (0.06 (95% CI: 0.03–0.15)) and VAP (0.39 (95% CI: 0.28–0.55)) when compared with intermittent control of cuff pressure. No significant differences in duration of MV (‐1.94 (95% CI: ‐4.06 to ‐0.17)), length of ICU stay (‐3.88 (95% CI: ‐9.00 to ‐1.23)) and mortality (0.99 (95% CI: 0.73–1.35)) were found between the two groups.Conclusions: Continuous control of cuff pressure offers more benefits in stabilizing the cuff pressure and reducing the incidence of VAP, and more studies are warranted to further evaluate the role of continuous control of cuff pressure.Relevance to practice: The continuous control of cuff pressure should be conducted whenever possible as it is the most ideal for the prognosis of MV patients.
- 9 December 2018
- Published by Wiley in Nursing in Critical Care
- Vol. 24 (2) , 76-82
Is continuous better than intermittent control of tracheal cuff pressure? A meta‐analysis
Aim: To compare and evaluate the efficacy and safety of continuous and intermittent control of cuff pressure.Methods: We performed a comprehensive and systematic meta‐analysis of randomized controlled trials (RCTs) assessing the continuous and intermittent control of Pcuff by searching PUBMED, EMBASE and other such databases (from inception to 31 March 2018). Summary odds ratios or mean differences with 95% confidence intervals were calculated using a fixed‐ or random‐effects model.Measurements and Main Results: Seven randomised controlled trials with 970 mechanically ventilated patients were included in this study. The continuous control of cuff pressure significantly reduced the incidence of cuff pressure < 20 cm H2O (0.03 (OR) (95% CI: 0.01–0.07)), Pcuff > 30 cm H2O (0.06 (95% CI: 0.03–0.15)) and VAP (0.39 (95% CI: 0.28–0.55)) when compared with intermittent control of cuff pressure. No significant differences in duration of MV (‐1.94 (95% CI: ‐4.06 to ‐0.17)), length of ICU stay (‐3.88 (95% CI: ‐9.00 to ‐1.23)) and mortality (0.99 (95% CI: 0.73–1.35)) were found between the two groups.Conclusions: Continuous control of cuff pressure offers more benefits in stabilizing the cuff pressure and reducing the incidence of VAP, and more studies are warranted to further evaluate the role of continuous control of cuff pressure.Relevance to practice: The continuous control of cuff pressure should be conducted whenever possible as it is the most ideal for the prognosis of MV patients.